ES8707964A1 - Un metodo para producir acidos tetrabasicos para su utilizacion en la terapia de los seres humanos y en veterinaria. - Google Patents

Un metodo para producir acidos tetrabasicos para su utilizacion en la terapia de los seres humanos y en veterinaria.

Info

Publication number
ES8707964A1
ES8707964A1 ES545783A ES545783A ES8707964A1 ES 8707964 A1 ES8707964 A1 ES 8707964A1 ES 545783 A ES545783 A ES 545783A ES 545783 A ES545783 A ES 545783A ES 8707964 A1 ES8707964 A1 ES 8707964A1
Authority
ES
Spain
Prior art keywords
alkyl
methylene
derivatives
aryl
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES545783A
Other languages
English (en)
Spanish (es)
Other versions
ES545783A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leo Pharma AS
Original Assignee
Leo Pharmaceutical Products Ltd AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharmaceutical Products Ltd AS filed Critical Leo Pharmaceutical Products Ltd AS
Publication of ES8707964A1 publication Critical patent/ES8707964A1/es
Publication of ES545783A0 publication Critical patent/ES545783A0/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3839Polyphosphonic acids
    • C07F9/386Polyphosphonic acids containing hydroxy substituents in the hydrocarbon radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/12Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ES545783A 1984-07-31 1985-07-31 Un metodo para producir acidos tetrabasicos para su utilizacion en la terapia de los seres humanos y en veterinaria. Expired ES8707964A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848419489A GB8419489D0 (en) 1984-07-31 1984-07-31 Chemical compounds

Publications (2)

Publication Number Publication Date
ES8707964A1 true ES8707964A1 (es) 1987-09-01
ES545783A0 ES545783A0 (es) 1987-09-01

Family

ID=10564711

Family Applications (1)

Application Number Title Priority Date Filing Date
ES545783A Expired ES8707964A1 (es) 1984-07-31 1985-07-31 Un metodo para producir acidos tetrabasicos para su utilizacion en la terapia de los seres humanos y en veterinaria.

Country Status (15)

Country Link
US (1) US4732998A (https=)
EP (1) EP0191044B1 (https=)
JP (1) JPH068303B2 (https=)
KR (1) KR860700254A (https=)
AU (1) AU583848B2 (https=)
DE (1) DE3575929D1 (https=)
DK (1) DK167808B1 (https=)
ES (1) ES8707964A1 (https=)
FI (1) FI861357A7 (https=)
GB (1) GB8419489D0 (https=)
GR (1) GR851865B (https=)
IE (1) IE58614B1 (https=)
PT (1) PT80886B (https=)
WO (1) WO1986000902A1 (https=)
ZA (1) ZA855264B (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3805663A1 (de) * 1988-02-24 1989-09-07 Henkel Kgaa Oxaalkanpolyphosphonsaeuren, ihre verwendung als thresholder sowie diese verbindungen enthaltende, komplexierend wirkende zusammensetzungen
DE3822650A1 (de) * 1988-07-05 1990-02-01 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
US5266722A (en) * 1988-11-09 1993-11-30 W. R. Grace & Co.-Conn. Polyether bis-phosphonic acid compounds
PH26923A (en) * 1989-03-08 1992-12-03 Ciba Geigy N-substituted amino alkanediphosphonic acids
FI83421C (fi) * 1989-06-21 1991-07-10 Huhtamaeki Oy Foerfarande foer framstaellning av farmakologiskt anvaendbara metylenbisfosfonsyraderivat.
US5227506A (en) * 1989-09-06 1993-07-13 Merck & Co., Inc. Acyloxymethyl esters of bisphosphonic acids as bone resorption inhibitors
DE69023844T2 (de) * 1989-09-06 1996-06-20 Merck & Co Inc Acyloxymethylester der Bisphonsäuren als Knochenresorptions-Inhibitoren.
GB9024345D0 (en) * 1990-11-08 1990-12-19 Merck Sharp & Dohme Therapeutic agents
JP3141053B2 (ja) * 1991-12-26 2001-03-05 アベンティス ファーマ株式会社 ビスホスホン酸誘導体
US5200554A (en) * 1992-01-21 1993-04-06 Nasman Jan Anders H Bisphosphonic acid derivatives and their use
WO1994001442A1 (fr) * 1992-07-10 1994-01-20 Toray Industries, Inc. Derive de methanediphosphonate, sa production, et son usage pharmaceutique
FR2703590B1 (fr) * 1993-04-05 1995-06-30 Sanofi Elf Utilisation de derives d'acide bisphosphonique pour la preparation de medicaments destines a favoriser la reparation osseuse .
US20010007863A1 (en) * 1998-06-18 2001-07-12 Merck & Co., Inc. Wet granulation formulation for bisphosphonic acids
US6143919A (en) * 1999-05-18 2000-11-07 3M Innovative Properties Company Polymerizable acidic compounds and methods of preparation
US6315566B1 (en) 1999-05-18 2001-11-13 3M Innovative Properties Company Dental materials
JP2005511526A (ja) * 2001-10-18 2005-04-28 イレックス プロダクツ インコーポレイテッド ジホスホネート誘導体による皮膚の治療方法
DE102004032781A1 (de) * 2004-01-23 2005-08-11 Mcs Micro Carrier Systems Gmbh Bisphosphonsäurederivate
JP2006028024A (ja) * 2004-07-12 2006-02-02 Toray Ind Inc リン含有有機化合物の製造方法。
EP2289900A1 (en) * 2009-08-26 2011-03-02 Humboldt Universität zu Berlin Bisphosphonates as inhibitors of acid sphingomyelinase
AU2013286683B2 (en) * 2012-07-05 2017-07-13 University Of Iowa Research Foundation Therapeutic bisphosphonates
US10557039B2 (en) * 2016-02-22 2020-02-11 Surfactis Technologies Compositions comprising bisphosphonic compounds dissolved in a fluorinated solvent, and use thereof for covering the surface of a part

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA777769A (en) * 1963-03-18 1968-02-06 H. Roy Clarence Substituted methylene diphosphonic acid compounds and detergent compositions
US3400131A (en) * 1964-03-05 1968-09-03 Hoffmann La Roche 1, 3-di (4-pyridyl)-2-propanol derivatives
GB1115044A (en) * 1964-08-06 1968-05-22 Albright & Wilson Mfg Ltd Derivatives of hydroxy diphosphonic acids
AT279051B (de) * 1966-12-29 1970-02-25 Procter & Gamble Mundpflegemittel
US3400151A (en) * 1967-12-28 1968-09-03 Procter & Gamble Bicyclic dimer of ethane-1-hydroxy-1, 1-diphosphonic acid and salts thereof
US4014959A (en) 1975-04-24 1977-03-29 Monsanto Company Phosphonoether carboxylates
SU772152A1 (ru) * 1977-07-20 1983-02-15 Центральный научно-исследовательский институт оловянной промышленности 1-Алкоксиалкилиден-1,1-дифосфоновые кислоты или их калиевые,натриевые или аммониевые соли в качестве собирателей дл флотации касситерита и способ их получени
IT1201087B (it) * 1982-04-15 1989-01-27 Gentili Ist Spa Bifosfonati farmacologicamente attivi,procedimento per la loro preparazione e relative composizioni farmaceutiche

Also Published As

Publication number Publication date
US4732998A (en) 1988-03-22
PT80886B (pt) 1987-11-30
DK147386D0 (da) 1986-04-01
KR860700254A (ko) 1986-08-01
FI861357A0 (fi) 1986-03-27
PT80886A (en) 1985-08-01
AU583848B2 (en) 1989-05-11
ZA855264B (en) 1986-03-26
JPH068303B2 (ja) 1994-02-02
GB8419489D0 (en) 1984-09-05
EP0191044B1 (en) 1990-02-07
DE3575929D1 (de) 1990-03-15
DK147386A (da) 1986-04-01
FI861357A7 (fi) 1986-03-27
AU4673685A (en) 1986-02-25
WO1986000902A1 (en) 1986-02-13
DK167808B1 (da) 1993-12-20
JPS61503034A (ja) 1986-12-25
IE58614B1 (en) 1993-10-20
GR851865B (https=) 1985-12-02
EP0191044A1 (en) 1986-08-20
IE851717L (en) 1986-01-31
ES545783A0 (es) 1987-09-01

Similar Documents

Publication Publication Date Title
ES8707964A1 (es) Un metodo para producir acidos tetrabasicos para su utilizacion en la terapia de los seres humanos y en veterinaria.
ES8101068A1 (es) Procedimiento para la preparacion de anilidas de acidos 4- amino-2-ureido-(o-tioureido)-pirimidin-5-carboxilicos
DE3375137D1 (en) Analogs of mevalolactone and derivatives thereof, processes for their production, pharmaceutical compositions containing them and their use as pharmaceuticals
DK142987A (da) Hidtil ukendte vitamin d-analoger
NZ236589A (en) A-nor-steroid-3-carboxylic acid derivatives and pharmaceutical compositions
HUP0102579A2 (hu) Antiangiogén hatású peptid gyógyszervegyületek, azokat tartalmazó gyógyszerkészítmények és alkalmazásuk
ES8201948A1 (es) Un procedimiento para la preparacion de nuevos derivados transisomericos de 4-fenil-1,2,3,4- tetrahidro-1-naftalenamina.
LU90366I2 (fr) Nasonex
PT77616B (en) Process for preparing imidazolylalkylthien-2-yl-tetrahydropyri-dazines and of pharmaceutical compositions containing the same
DK162883D0 (da) N-glucosylerede carboxylsyreamidderivater, fremgangsmade til fremstilling heraf samt deres anvendelse til pavirkning af organismens egen forsvarsmekanisme
ES8401960A1 (es) Procedimiento para la preparacion de imidazolilfenil-tetrahidropiridazinas.
EP0393494A3 (en) Bile acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
ES8200094A1 (es) Procedimiento para la obtencion de alquilureas
DE3064835D1 (en) 2-hydroxyalkyl-3,4,5,trihydroxy piperidines, processes for their preparation and their use as medicaments
HUT55034A (en) Process for producing peptides with hemoregulating effect and pharmaceutical compositions comprising such compounds as active ingredient
FR2581382B1 (fr) Derives n-(quinolyl) glycinamides, leur procede de preparation et leur application therapeutique en tant que psychotropes
HUT53664A (en) Process for producing enzyme inhibiting amino acid derivatives and pharmaceutical compositions comprising such compounds as active ingredient
JO1677B1 (en) 3,3 'compounds - dithiobase (prepernic acid) and its organic salts
ES483661A1 (es) Procedimiento para la obtencion de derivados de 1,4-dihidro-piridina sila-sustituidos
ZA803330B (en) New 3,4,5-trihydroxypiperidine compounds, their production and their use as medicamnets and in animal nutrition
IL108856A0 (en) Hydroxymethyl-furazancarboxylic acid derivatives, their preparation and pharmaceutical compositions containing them
GB1195200A (en) Pharmaceutical Compositions.
ES8802612A1 (es) Procedimiento para preparar derivados de benzisoselenazolilo
IL66960A0 (en) 4-phenyl-quinazoline derivatives,their preparation and pharmaceutical compositions containing them
ES8305717A1 (es) Procedimiento para la obtencion de derivados de 2-amino-3,4-dihidropiridina sustituidos.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970612